Các bài viết có thể truy cập công khai - Robert McWilliamsTìm hiểu thêm
Không có ở bất kỳ nơi nào: 4
Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial.
RR McWilliams, MR Mahoney, BT Marchello, A Jatoi, KD Krewer, ...
Journal of Clinical Oncology 30 (4_suppl), 314-314, 2012
Các cơ quan ủy nhiệm: US National Institutes of Health
SALVO: single-arm trial of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma
LA Kottschade, GR Pond, AJ Olszanski, Y Zakharia, E Domingo-Musibay, ...
Clinical Cancer Research 29 (12), 2220-2225, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health
Outcomes following FGFR inhibitor therapy in patients with cholangiocarcinoma
JJ Gile, V Wookey, TJ Zemla, Q Shi, Z Jin, SR Alberts, RR McWilliams, ...
Targeted Oncology 17 (5), 529-538, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health
Utility of mismatch repair protein expression screening via an endoscopic ultrasound assessment of treatment-naive pancreas ductal adenocarcinoma
AGG De Paredes, RP Graham, MJ Levy, RR McWilliams, E Rajan, ...
Gut 71 (1), 219-221, 2022
Các cơ quan ủy nhiệm: Research Foundation (Flanders)
Có tại một số nơi: 97
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
S Kopetz, GJ Chang, MJ Overman, C Eng, DJ Sargent, DW Larson, ...
Journal of clinical oncology 27 (22), 3677-3683, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
L Amundadottir, P Kraft, RZ Stolzenberg-Solomon, CS Fuchs, ...
Nature genetics 41 (9), 986-990, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Detectable clonal mosaicism and its relationship to aging and cancer
KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ...
Nature genetics 44 (6), 651-658, 2012
Các cơ quan ủy nhiệm: US National Institutes of Health, Cancer Research UK
Integrated genomic characterization of pancreatic ductal adenocarcinoma
BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ...
Cancer cell 32 (2), 185-203. e13, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health, Cancer Research UK, UK Medical Research …
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22. 1, 1q32. 1 and 5p15. 33
GM Petersen, L Amundadottir, CS Fuchs, P Kraft, ...
Nature genetics 42 (3), 224-228, 2010
Các cơ quan ủy nhiệm: US National Institutes of Health
Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer
C Hu, SN Hart, EC Polley, R Gnanaolivu, H Shimelis, KY Lee, J Lilyquist, ...
Jama 319 (23), 2401-2409, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
F Meric-Bernstam, H Hurwitz, KPS Raghav, RR McWilliams, M Fakih, ...
The Lancet Oncology 20 (4), 518-530, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
AA Arslan, KJ Helzlsouer, C Kooperberg, XO Shu, E Steplowski, ...
Archives of internal medicine 170 (9), 791-802, 2010
Các cơ quan ủy nhiệm: US National Institutes of Health, National Institute of Health and Medical …
Non-V600BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer
JC Jones, LA Renfro, HO Al-Shamsi, AB Schrock, A Rankin, BY Zhang, ...
Journal of Clinical Oncology 35 (23), 2624-2630, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma
MJ Borad, MD Champion, JB Egan, WS Liang, R Fonseca, AH Bryce, ...
PLoS genetics 10 (2), e1004135, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
DB Zhen, KG Rabe, S Gallinger, S Syngal, AG Schwartz, MG Goggins, ...
Genetics in Medicine 17 (7), 569-577, 2015
Các cơ quan ủy nhiệm: US National Institutes of Health
Preoperative treatment of locally advanced rectal cancer
D Schrag, Q Shi, MR Weiser, MJ Gollub, LB Saltz, BL Musher, J Goldberg, ...
New England Journal of Medicine 389 (4), 322-334, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health
Long-Term Outcomes in Patients With BRAF V600–Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
GV Long, Z Eroglu, J Infante, S Patel, A Daud, DB Johnson, R Gonzalez, ...
Journal of Clinical Oncology 36 (7), 667-673, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor
SJ Murphy, SN Hart, JF Lima, BR Kipp, M Klebig, JL Winters, C Szabo, ...
Gastroenterology 145 (5), 1098-1109. e1, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF …
DB Johnson, KT Flaherty, JS Weber, JR Infante, KB Kim, RF Kefford, ...
Journal of Clinical Oncology 32 (33), 3697-3704, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health
Phase III prospective randomized comparison trial of depot octreotide plus interferon alfa-2b versus depot octreotide plus bevacizumab in patients with advanced carcinoid …
JC Yao, KA Guthrie, C Moran, JR Strosberg, MH Kulke, JA Chan, ...
Journal of Clinical Oncology 35 (15), 1695-1703, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ